Form 8-K - Current report:
SEC Accession No. 0001493152-25-009737
Filing Date
2025-03-10
Accepted
2025-03-10 17:27:22
Documents
17
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55937
2 ex1-1.htm EX-1.1 356083
3 ex99-1.htm EX-99.1 32159
4 ex1-1_001.jpg GRAPHIC 8498
5 ex99-1_001.jpg GRAPHIC 4958
  Complete submission text file 0001493152-25-009737.txt   704765

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE meds-20250304.xsd EX-101.SCH 3009
7 XBRL LABEL FILE meds-20250304_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE meds-20250304_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 25725003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)